StockVS

Teleflex Incorporated (TFX) स्टॉक विश्लेषण

स्वास्थ्य सेवा

Teleflex Incorporated

$131.89

$-0.86 (-0.65%)

अंतिम अपडेट: 26 मई 2026

प्राइस हिस्ट्री

हाल की खबरें

तृतीय-पक्ष स्रोतों द्वारा प्रदान की गई समाचार। वित्तीय सलाह नहीं है।

विश्लेषण

कंपनी का अवलोकन

Teleflex Incorporated operates as a prominent manufacturer and supplier of single-use medical devices designed for critical care and surgical applications across the United States, Europe, the Middle East, Africa, Asia Pacific, and international markets. The enterprise functions within the Healthcare sector, specifically targeting the Medical Instruments & Supplies industry, which implies a focus on essential diagnostic and therapeutic equipment for medical professionals. The company's scale is defined by a market capitalization of $5.26B, an annual revenue of $1.99B over the trailing twelve months, and an operational workforce comprising 15,500 employees. These valuation and revenue figures indicate that Teleflex holds a significant position in the global medical device landscape, possessing substantial resources to support extensive distribution networks and R&D capabilities despite operating in a capital-intensive industry.

वित्तीय स्वास्थ्य

The company reported a revenue of $1.99B, a net income of $58.53M, and an EBITDA of $469.19M for the trailing twelve months, revealing a complex cost structure where operating expenses significantly erode bottom-line profitability relative to total sales. The free cash flow stands at $12.83M, which suggests limited financial flexibility for aggressive capital expenditure or large-scale acquisitions given the narrow cash generation relative to the overall revenue base. Profitability metrics show a gross margin of 56.4% and an operating margin of 40.6%, indicating strong pricing power and efficient internal cost management at the operational level. However, the profit margin is reported at -45.4%, which highlights severe non-operating costs or significant interest expenses that drastically reduce the final profit available to shareholders. The balance sheet presents a leveraged profile with total debt of $2.82B against cash reserves of $404.82M, resulting in a debt-to-equity ratio of 90.32% that reflects a high reliance on borrowed capital. Liquidity position remains robust with a current ratio of 2.54, signaling that the company holds more than double the current assets required to cover its short-term liabilities. Return on equity is measured at 1.6% and return on assets at 2.6%, metrics that suggest management effectiveness is currently constrained by the high debt load and the aforementioned negative profit margin.

मूल्यांकन आकलन

The trailing twelve-month P/E ratio is 90.86, while the forward P/E is projected at 11.74, a stark disparity that implies the market expects a dramatic and rapid improvement in future earnings relative to current performance. The price-to-book ratio of 1.68 indicates that the stock trades at a moderate premium over its book value, suggesting investors are pricing in future growth potential despite current earnings challenges. Alternative valuation metrics such as the price-to-sales ratio of 2.64 and an EV/EBITDA of 16.37 provide context that the company is valued based on revenue multiple rather than current earnings power, often seen in turnaround situations. The stock price has historically ranged between a 52-week low of $100.18 and a 52-week high of $138.93, with the current trading position situated within this established volatility range. The beta value of 0.83 indicates that Teleflex exhibits lower price volatility than the broader market, moving less aggressively than the overall index during periods of market fluctuation.

Growth & Income

Both revenue growth year-over-year and earnings growth year-over-year are listed as N/A in the available data, preventing a direct comparison of whether earnings are expanding faster or slower than sales in the most recent period. As a company paying dividends, Teleflex offers a dividend yield of 1.1% with a payout ratio of 103.8%, a figure that exceeds earnings and indicates the dividend is not fully covered by current profitability. This payout ratio suggests the company is relying on cash reserves or debt service capacity to maintain the dividend rather than distributing actual net income, which poses a sustainability risk if operating conditions do not improve immediately. The overall growth and income profile currently reflects a mature asset with limited reported growth metrics and a dividend structure that requires careful monitoring regarding its coverage by earnings.

समकक्ष तुलना

Teleflex Incorporated (TFX) चिकित्सा उपकरण और आपूर्ति उद्योग में कार्यरत है। बाजार पूंजीकरण के आधार पर इसके निकटतम समकक्षों से तुलना इस प्रकार है:

कंपनी टिकर मार्केट कैप P/E अनुपात
Teleflex Incorporated TFX $5.84B 1884.1
Intuitive Surgical, Inc. ISRG $154.64B 53.2
Becton, Dickinson and Company BDX $40.71B 25.8
Alcon Inc. ALC $33.02B 40.5

चिकित्सा उपकरण और आपूर्ति उद्योग का औसत P/E अनुपात 208.0x है। Teleflex Incorporated का P/E अनुपात 1884.1 है।

यह विश्लेषण AI द्वारा केवल सूचनात्मक उद्देश्यों के लिए तैयार किया गया है और यह वित्तीय सलाह नहीं है। डेटा में देरी या अशुद्धि हो सकती है। निवेश निर्णय लेने से पहले हमेशा अपना शोध करें और किसी योग्य वित्तीय सलाहकार से परामर्श लें।

Teleflex Incorporated के बारे में

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

कंपनी विवरण अंग्रेजी में दिखाया गया है।

वेबसाइट देखें →

मुख्य आंकड़े

मार्केट कैप
$5.84B
P/E अनुपात
1884.14
52 सप्ताह उच्च
$139.67
52 सप्ताह निम्न
$100.18
औसत वॉल्यूम
850.06K
बीटा
0.81
डिविडेंड यील्ड
1.03%

डेटा yfinance के माध्यम से Yahoo Finance द्वारा प्रदान किया गया है। दैनिक अपडेट।

कंपनी जानकारी

एक्सचेंज
NYSE
देश
United States
कर्मचारी
15,500